See Your Future More Clearly with Valeda
The first approved light-based therapy for Dry Age-Related Macular Degeneration (AMD), improving vision and preserving sight without injections or surgery.
What Is Dry AMD?
Dry AMD is the most common cause of vision loss in people over 65. It damages the retina, making it harder to read, drive, recognize faces, or see in low light.
Symptoms May Include:
Blurry or fuzzy vision
Straight lines appear wavy
Difficulty adapting to low light
Reduced brightness of colors
Loss of central vision
Early treatment makes a difference. Once retinal cells are lost, they cannot be restored. That’s why starting Valeda treatment early is essential.
Treatment with Valeda improves visual acuity and contrast sensitivity and reduces central drusen volume.
Lumithera Treatment
Dry AMD is a degenerative disease and may result in vision loss
How Valeda Works
Valeda uses specific wavelengths of light—590nm, 660nm, and 850nm—to stimulate energy production in damaged retinal cells.
This process is called Photobiomodulation (PBM). It helps:
Restore cellular metabolism (via ATP production)
Reduce inflammation
Inhibit cell death
Improve oxygen utilization
In simple terms: Valeda helps the eye heal itself naturally using the power of light.
FAQs
A: Not at all. It’s comfortable and non-invasive, with no eye drops or injections required.
A: 9 sessions per cycle over 3–5 weeks. Repeat cycles every 4 months, based on doctor recommendation.
A: Yes. Valeda has shown no treatment-related side effects in clinical trials.
A: While there is no cure for dry AMD, Valeda helps improve and maintain vision by treating the underlying cell damage.
A: Book a consultation with your eye specialist today to see if Valeda is right for you.